IN2013MU03847A - - Google Patents

Info

Publication number
IN2013MU03847A
IN2013MU03847A IN3847MU2013A IN2013MU03847A IN 2013MU03847 A IN2013MU03847 A IN 2013MU03847A IN 3847MU2013 A IN3847MU2013 A IN 3847MU2013A IN 2013MU03847 A IN2013MU03847 A IN 2013MU03847A
Authority
IN
India
Prior art keywords
composition
relates
linagliptin
devoid
amino acids
Prior art date
Application number
Other languages
English (en)
Inventor
Patel Priyank
Patel Mayur
Patel Mahendra
Sehgal Ashish
Original Assignee
Intas Pharmaceuticals Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Intas Pharmaceuticals Ltd filed Critical Intas Pharmaceuticals Ltd
Priority to IN3847MU2013 priority Critical patent/IN2013MU03847A/en
Priority to PCT/IN2014/000751 priority patent/WO2015107536A2/en
Publication of IN2013MU03847A publication Critical patent/IN2013MU03847A/en

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A61K31/519Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim ortho- or peri-condensed with heterocyclic rings
    • A61K31/52Purines, e.g. adenine
    • A61K31/522Purines, e.g. adenine having oxo groups directly attached to the heterocyclic ring, e.g. hypoxanthine, guanine, acyclovir
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/13Amines
    • A61K31/155Amidines (), e.g. guanidine (H2N—C(=NH)—NH2), isourea (N=C(OH)—NH2), isothiourea (—N=C(SH)—NH2)
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/20Pills, tablets, discs, rods
    • A61K9/2004Excipients; Inactive ingredients
    • A61K9/2022Organic macromolecular compounds
    • A61K9/205Polysaccharides, e.g. alginate, gums; Cyclodextrin
    • A61K9/2059Starch, including chemically or physically modified derivatives; Amylose; Amylopectin; Dextrin
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/20Pills, tablets, discs, rods
    • A61K9/2072Pills, tablets, discs, rods characterised by shape, structure or size; Tablets with holes, special break lines or identification marks; Partially coated tablets; Disintegrating flat shaped forms
    • A61K9/2086Layered tablets, e.g. bilayer tablets; Tablets of the type inert core-active coat
    • A61K9/209Layered tablets, e.g. bilayer tablets; Tablets of the type inert core-active coat containing drug in at least two layers or in the core and in at least one outer layer
IN3847MU2013 2013-12-09 2014-12-05 IN2013MU03847A (es)

Priority Applications (2)

Application Number Priority Date Filing Date Title
IN3847MU2013 IN2013MU03847A (es) 2013-12-09 2014-12-05
PCT/IN2014/000751 WO2015107536A2 (en) 2013-12-09 2014-12-05 Fixed dose combination comprising linagliptin and metformin hci

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
IN3847MU2013 IN2013MU03847A (es) 2013-12-09 2014-12-05

Publications (1)

Publication Number Publication Date
IN2013MU03847A true IN2013MU03847A (es) 2015-07-24

Family

ID=53543573

Family Applications (1)

Application Number Title Priority Date Filing Date
IN3847MU2013 IN2013MU03847A (es) 2013-12-09 2014-12-05

Country Status (2)

Country Link
IN (1) IN2013MU03847A (es)
WO (1) WO2015107536A2 (es)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
TR201721505A2 (tr) * 2017-12-25 2019-07-22 Sanovel Ilac Sanayi Ve Ticaret Anonim Sirketi Li̇nagli̇pti̇n ve metformi̇n i̇çeren kombi̇nasyon
TR201721824A2 (tr) * 2017-12-26 2019-07-22 Sanovel Ilac Sanayi Ve Ticaret Anonim Sirketi Li̇nagli̇pti̇n ve metformi̇n i̇çeren modi̇fi̇ye salim sağlayan kombi̇nasyon
WO2023002036A1 (en) 2021-07-22 2023-01-26 Krka, D.D., Novo Mesto Process for preparing a pharmaceutical composition comprising linagliptin and metformin hydrochloride
CN116211819A (zh) * 2023-04-12 2023-06-06 华润双鹤药业股份有限公司 一种利格列汀盐酸二甲双胍多层片及其制备方法

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
UY33937A (es) * 2011-03-07 2012-09-28 Boehringer Ingelheim Int Composiciones farmacéuticas que contienen inhibidores de dpp-4 y/o sglt-2 y metformina
US9555001B2 (en) * 2012-03-07 2017-01-31 Boehringer Ingelheim International Gmbh Pharmaceutical composition and uses thereof

Also Published As

Publication number Publication date
WO2015107536A3 (en) 2015-11-26
WO2015107536A2 (en) 2015-07-23

Similar Documents

Publication Publication Date Title
PH12016501139B1 (en) Bicyclic heterocycle compounds and their uses in therapy
PH12015500274B1 (en) Alkylpyrimidine derivatives for the treatment of viral infections and further diseases
IN2014MN02069A (es)
IN2014MN00948A (es)
IN2014MN00986A (es)
IN2014MN00987A (es)
PH12014501984A1 (en) Pharmaceutical compositions comprising metformin and a dpp-4 inhibitor or a sglt-2 inhibitor
IN2014MN02049A (es)
PH12015500713B1 (en) Acylaminopyrimidine derivatives for the treatment of viral infections and further diseases
IN2012MN02591A (es)
MX347966B (es) Derivados de quinazolina para el tratamiento de infecciones viricas y otras enfermedades.
IN2015DN01164A (es)
MY181828A (en) Bicyclically substituted uracils and the use therapy
MY182558A (en) 1,2,4-triazine derivatives for the treatment of viral infections
IN2015DN01165A (es)
PH12016502352A1 (en) Pharmaceutical composition
TW201613578A (en) Pharmaceutical combinations
IN2013MU03847A (es)
PH12017501694A1 (en) Compositions for the treatment of fibrosis and fibrosis-related diseases
PH12015501179A1 (en) Fixed dose pharmaceutical composition comprising mometasone and azelastine
IN2014DN10683A (es)
IN2013MU01223A (es)
IN2013MU01222A (es)
IN2013MU01225A (es)
IN2013MU01224A (es)